Ngā hua rapu - Cheraghchi-Bashi, Azadeh

  • E whakaatu ana i te 1 - 2 hua o te 2
Whakamahine hua
  1. 1
    Identification of anticancer drugs to radiosensitise BRAF-wild-type and mutant colorectal cancer

    Identification of anticancer drugs to radiosensitise BRAF-wild-type and mutant colorectal cancer mā Carter, Rebecca, Cheraghchi-Bashi, Azadeh, Westhorpe, Adam, Yu, Sheng, Shanneik, Yasmin, Seraia, Elena, Ouaret, Djamila, Inoue, Yasuhiro, Koch, Catherine, Wilding, Jenny, Ebner, Daniel, Ryan, Anderson J., Buffa, Francesca M., Sharma, Ricky A.

    I whakaputaina 2019
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Combined inhibition of mTOR and CDK4/6 is required for optimal blockade of E2F function and long term growth inhibition in estrogen receptor positive breast cancer

    Combined inhibition of mTOR and CDK4/6 is required for optimal blockade of E2F function and long term growth inhibition in estrogen receptor positive breast cancer mā Michaloglou, Chrysiis, Crafter, Claire, Siersbæk, Rasmus, Delpuech, Oona, Curwen, Jon, Carnevalli, Larissa S., Staniszewska, Anna D., Polanska, Urszula M., Cheraghchi-Bashi, Azadeh, Lawson, Mandy, Chernukhin, Igor, McEwen, Robert, Carroll, Jason S., Cosulich, Sabina C.

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: